Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - AYTU BIOPHARMA, INC | d99194d10q.htm |
| EX-31.2 - EX-31.2 - AYTU BIOPHARMA, INC | d99194dex312.htm |
| EX-10.1 - EX-10.1 - AYTU BIOPHARMA, INC | d99194dex101.htm |
| EX-31.1 - EX-31.1 - AYTU BIOPHARMA, INC | d99194dex311.htm |
Exhibit 32.1
AYTU BIOSCIENCE, INC.
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended September 30, 2015 (the “Report”) by Aytu BioScience, Inc. (the “Company”), each of the undersigned hereby certifies that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: November 6, 2015 |
/s/ Joshua R. Disbrow | |||||
| Joshua R. Disbrow | ||||||
| Chief Executive Officer | ||||||
| Dated: November 6, 2015 |
/s/ Gregory A. Gould | |||||
| Gregory A. Gould | ||||||
| Chief Financial Officer | ||||||